Solid Biosciences Inc. (SLDB) — 10-Q Filings

10-Q Filings (6)

• Solid Biosciences' R&D Surge Drives 52% Net Loss Increase — Nov 3, 2025 Risk: high
  Solid Biosciences Inc. reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $124.5 million, up from $82.1 million
• Solid Biosciences' Q2 Loss Widens to $25.2M Amid R&D Shifts — Aug 12, 2025 Risk: high
  Solid Biosciences Inc. reported a net loss of $25.2 million for the three months ended June 30, 2025, a significant increase from the $19.9 million net loss for
• Solid Biosciences Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  Solid Biosciences Inc. filed its 10-Q for the period ending March 31, 2025. The company reported on its operating segments and various financial items, includin
• Solid Biosciences Files Q3 2024 10-Q — Nov 6, 2024 Risk: medium
  Solid Biosciences Inc. filed its 10-Q for the period ending September 30, 2024. The company, focused on biological products, reported on its financial status an
• Solid Biosciences Files Q2 2024 10-Q — Aug 13, 2024 Risk: medium
  Solid Biosciences Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and operational highlights. Key financial
• Solid Biosciences Files Q1 2024 10-Q — May 15, 2024 Risk: medium
  Solid Biosciences Inc. filed its 10-Q for the period ending March 31, 2024. The company reported on its financial position and business operations, including de

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX